Latest TriVascular Inc. Stories

2014-01-27 23:28:05

500-patient, real-world study of innovative, lowest profile EVAR system bolsters strong library of clinical evidence. Santa Rosa, CA (PRWEB) January 27, 2014 TriVascular, Inc. today announced the enrollment completion of the OVATION post-market registry, a 500-patient, 30-center European study. The multicenter prospective post-market registry evaluates the safety and performance of the Ovation and Ovation Prime™ Abdominal Stent Graft Systems, with patient follow-up out to five years....

2013-11-18 23:31:37

Proceeds to Support Commercialization, Product Development and Clinical Research Efforts Santa Rosa, CA (PRWEB) November 18, 2013 TriVascular, Inc. today announced the close of a $40 million Series E Preferred Stock equity financing. Existing investors New Enterprise Associates, Delphi Ventures, MPM Capital, Kearny Venture Partners, Kaiser Permanente Ventures and the Redmile Group were joined by new investors Deerfield Management, Rock Springs Capital and Permal Asset Management in the...

2013-08-27 23:33:14

Outcomes demonstrate excellent safety and effectiveness in the treatment of patients with Abdominal Aortic Aneurysms (AAA). Santa Rosa, CA (PRWEB) August 27, 2013 The Journal of Vascular Surgery (JVS), the worldwide leader in providing original, peer-reviewed articles on Endovascular Aortic Repair (EVAR), published the one-year outcomes from the TriVascular Ovation global pivotal study. The article concluded the “one-year outcomes with the Ovation stent graft are promising with...

2013-07-17 23:20:11

Over 2000 patients have been treated with innovative 14 French Endovascular Aortic Repair (EVAR) device. Santa Rosa, CA (PRWEB) July 17, 2013 TriVascular, Inc. announced today the initiation of a U.S. Post-Approval Study (PAS) of the Ovation Prime Abdominal Stent Graft System for the treatment of abdominal aortic aneurysms (AAA). The study’s national principal investigator will be Dr. Syed Hussain, Director of Vascular and Endovascular Surgery at OSF/HeartCare MidWest and Assistant...

2011-07-25 13:19:00

SANTA ROSA, Calif., July 25, 2011 /PRNewswire/ -- TriVascular, Inc. today announced the successful treatment of the first 5 patients in the OVATION study, a multicenter, prospective, European Post Market Registry. The patients were treated in Germany at Stadtisches Klinikum, Karlsruhe by Prof. Martin Storck and at Universitares Herz und Gefasszentrum, Hamburg by Dr. Hans Krankenberg. "It is an honor to be the first site to enroll a patient in TriVascular's OVATION study. Ovation's...

Word of the Day
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.